InsidersTradesSigma
Follow the Nanologica AB (publ) share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Nanologica AB (publ) has logged 4 public disclosures. Market capitalisation: €150.2m. The latest transaction was reported on 21 April 2026 (Purchase). Among the most active insiders: Thomas Eldered. All data is openly available.
4
Insider Decl.
n/a
Thresholds
€920,347
3 ops.
Buy Volume
n/a
n/a
Sell Volume
36Σ signal
Fundamental score
Ranked 22,216 of 29,064 companies
33.4
score / 100
Value7
Quality59
FCF yld-28%
Earn yld-35%
EV/EBITDA·
ROE30%
Gross mgn20%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 April 2026
Declarations4 total
2,600,000 shares@ €0.03720.059% mcap100.0% of flowAktieISIN SE0005454873FI:A003X713-1
38,516,592 shares0Teckningsrätt/UniträttISIN SE0028001008FI:A003X483-1
21,453,780 shares@ €0.03720.49% mcap100.0% of flowAktieISIN SE0005454873FI:A003X186-1
293,815 shares@ €0.08840.016% mcap100.0% of flowAktieISIN SE0005454873FI:A003Q717-1
4 of 4 declarations
关于 Nanologica AB (publ)
Nanologica AB (publ) 是一家瑞典公司，专注于开发创新的药物输送解决方案。该公司在 XSTO 市场上市。